Edwards Lifesciences Corporation (EW) Stock Overview
Explore Edwards Lifesciences Corporation’s financial performance, market position, analyst ratings, and future outlook.
Edwards Lifesciences Corporation (EW)
Key Financials
Key Financials
Market Cap
60.9B
P/E Ratio
59.79
EPS (TTM)
$2.70
ROE
0.10%
EW Stock Analysis & Investment Overview (NYSE)
Our AI-powered analysis of Edwards Lifesciences Corporation (NYSE: EW) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Edwards Lifesciences Corporation's NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of EW on the NYSE shows an RSI of 78.95, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $89.26 for the NYSE listing.
Key metrics behind Edwards Lifesciences Corporation's NYSE-traded stock include a P/E ratio of 59.79 and a market capitalization of 60.9B. Combined with our AI analysis, these give both institutional and retail investors a clear view of EW on the NYSE.